MVA/HIV62B

Modified Vaccinia Ankara expressing HIV-1 antigens 62B

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA/HIV62B, covering 2021-04-01 to 2021-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205 [Phase 1]

See pricing